Pegarginase - Enzon Pharmaceuticals

Drug Profile

Pegarginase - Enzon Pharmaceuticals

Alternative Names: Arginase macrogol; PEG-arginase - Enzon Pharmaceuticals; Polyethylene glycol arginase

Latest Information Update: 29 Apr 2011

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Enzon Pharmaceuticals
  • Class Antineoplastics; Polyethylene glycols; Ureohydrolases
  • Mechanism of Action Arginase replacements
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity No

Highest Development Phases

  • Discontinued Cancer

Most Recent Events

  • 08 Sep 1998 Profile reviewed
  • 08 Sep 1998 No-Development-Reported for Cancer in USA (Unknown route)
  • 22 Aug 1996 Preclinical development for Cancer in USA (Unknown route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top